ALFA Filings
Every announcement, straight from the exchange
Every Suven Life Sciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Suven Life Sciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI regulations.
Suven Life Sciences Limited submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report confirms the utilization of Rs. 857.64 Crore raised via preferential issue.
Suven Life Sciences has provided a web-link to its Annual Report for FY 2025-2026. This notice informs shareholders whose email addresses are not registered.